Exploratory Clinical Study of Time to Onset of Glucagon Effect by Administration Route in Colonoscopy

Exploratory Clinical Study of Time to Onset of Glucagon Effect by Administration Route in Colonoscopy - Exploratory Clinical Study of Time to Onset of Glucagon Effect by Administration Route in Colonoscopy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000058984

Enrollment

Registered

2025-09-05

Start date

2025-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for colonoscopy under sedation

Interventions

Intramuscular administration of glucagon Intravenous administration of glucagon

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for colonoscopy under sedation 2.Patients who provided written informed consent to participate in the study 3.Patients aged 20 years or older and younger than 75 years at the time of enrollment 4.Patients scheduled to receive glucagon as an antispasmodic agent

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to glucagon 2.Patients with inflammatory bowel disease 3.Patients with a history of colorectal surgery

Design outcomes

Primary

Measure	Time frame
Time to onset of peristalsis inhibition after intramuscular and intravenous administration of glucagon	—

Countries

Japan

Contacts

Public ContactYutaka Okagawa

Sapporo Medical University School of Medicine Division of Medical Oncology

okagawayutaka@sapmed.ac.jp08046035753

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026